Stock NLSP NLS PHARMACEUTICS AG
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart NLS Pharmaceutics AG

Equities

NLSP

CH0523961370

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-14 EDT 		5-day change 1st Jan Change
0.1139 USD -1.96% Intraday chart for NLS Pharmaceutics AG -10.81% -80.69%
06-11 NLS Pharmaceutics AG Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists CI
06-11 NLS Pharmaceutics Says New Patent Application for Dual Non-Sulfonamide Orexin Receptor Agonists Published by WIPO MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NLS PHARMACEUTICS AG
Other Biotechnology & Medical Research
-1.96%-10.81%-80.69%-87.55% - 4.57M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NLSP Stock
  4. Charts NLS Pharmaceutics AG
  5. Comparison Chart